Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-10-037406
Filing Date
2010-07-12
Accepted
2010-07-12 09:40:06
Documents
1
Period of Report
2010-07-08

Document Format Files

Seq Description Document Type Size
1 v190366_ex.html 4  
1 v190366_ex.xml 4 3664
  Complete submission text file 0001144204-10-037406.txt   5587
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 415 EAST 37TH STREET APT 36C NEW YORK NY 10016
Business Address
Berelowitz Michael (Reporting) CIK: 0001493383 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50298 | Film No.: 10947331